Lung Ultrasound Surface Wave Elastography for Assessing Interstitial Lung Disease

Objective: Our goal is to translate lung ultrasound surface wave elastography (LUSWE) for assessing patients with interstitial lung disease (ILD) and various connective tissue diseases including systemic sclerosis (SSc). Methods: LUSWE was used to measure the surface wave speed of lung at 100, 150,...

Full description

Saved in:
Bibliographic Details
Published inIEEE transactions on biomedical engineering Vol. 66; no. 5; pp. 1346 - 1352
Main Authors Zhang, Xiaoming, Zhou, Boran, Osborn, Thomas, Bartholmai, Brian, Kalra, Sanjay
Format Journal Article
LanguageEnglish
Published United States IEEE 01.05.2019
The Institute of Electrical and Electronics Engineers, Inc. (IEEE)
Subjects
Online AccessGet full text
ISSN0018-9294
1558-2531
1558-2531
DOI10.1109/TBME.2018.2872907

Cover

More Information
Summary:Objective: Our goal is to translate lung ultrasound surface wave elastography (LUSWE) for assessing patients with interstitial lung disease (ILD) and various connective tissue diseases including systemic sclerosis (SSc). Methods: LUSWE was used to measure the surface wave speed of lung at 100, 150, and 200 Hz through six intercostal lung spaces for 91 patients with ILD and 30 healthy control subjects. In addition, skin viscoelasticity was measured on both forearms and upper arms for patients and controls. Results: The surface wave speeds of patients' lungs were significantly higher than those of control subjects. Patient skin elasticity and viscosity were significantly higher than those of control subjects. In dividing ILD patients into two groups, ILD with SSc patients and ILD without SSc patients, significant differences between each patient group with the control group were found for both the lung and skin. No significant differences were found between the two patient groups, although there were some differences at a few locations and at 100 Hz for skin viscoelasticity. Conclusion: Significant differences of surface wave speed were found between ILD patients and healthy control subjects for both the lung and skin. Significance: LUSWE may be useful for assessing ILD and SSc and screening early stage patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0018-9294
1558-2531
1558-2531
DOI:10.1109/TBME.2018.2872907